Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
15604339
PubMed Central
PMC1768627
DOI
10.1136/hrt.2003.026419
PII: 91/1/73
Knihovny.cz E-zdroje
- MeSH
- bypass pravého srdce * MeSH
- cholestáza etiologie MeSH
- dítě MeSH
- dospělí MeSH
- hemokoagulace * MeSH
- játra patofyziologie MeSH
- koagulační faktory analýza MeSH
- krevní proteiny analýza MeSH
- lidé MeSH
- mladiství MeSH
- následné studie MeSH
- pooperační období MeSH
- předškolní dítě MeSH
- průřezové studie MeSH
- vrozené srdeční vady krev patofyziologie chirurgie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- koagulační faktory MeSH
- krevní proteiny MeSH
OBJECTIVE: To examine coagulation factors and liver function test abnormalities in patients after total cavopulmonary connection (TCPC). DESIGN: Cross sectional study comprising clinical and echocardiographic evaluation, and biochemical and coagulation profile screening. SETTING: Tertiary referral centre. METHODS: 102 patients aged 4-24 years (median 10 years) at one to eight years (median five years) after TCPC were examined. All patients were maintained on a low dose of aspirin. 96% of patients were in a good clinical condition (New York Heart Association class I or II). No intracardiac thrombi were detected on echocardiography and ventricular function was good in 91% of patients. RESULTS: Total bilirubin was increased in 27% and gamma glutamyltransferase in 54% of patients. Serum total protein, albumin, and prealbumin were normal in almost in all patients. Compared with the control group, patients after TCPC had significantly lower fibrinogen, factor V, factor VII, and protein C concentrations, prolonged international normalised ratio, and increased antithrombin III concentration. Factor V concentration was abnormally decreased in 35%, factor VII in 16%, and protein C in 28% of patients. Antithrombin III was increased in 23% of patients. Factor VII, factor V, protein C, and antithrombin III correlated significantly with serum prealbumin. There was also a significant correlation between procoagulant factor VII and both anticoagulant protein C and antithrombin III. CONCLUSIONS: Almost half of patients after TCPC had laboratory signs of mild cholestasis. Decreased liver synthesis of procoagulant and anticoagulant factors was observed but overall coagulation homeostasis appeared to be in balance in this selected group of patients with a good clinical outcome.
Zobrazit více v PubMed
Kaulitz R, Luhmer I, Bergmann F, et al. Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 1997;78:154–9. PubMed PMC
Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001;121:28–41. PubMed
Naschitz JE, Slobodin G, Lewis RJ, et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000;140:111–20. PubMed
Mace S, Borkat G, Liebman J. Hepatic dysfunction and cardiovascular abnormalities: occurrence in infants, children, and young adults. Am J Dis Child 1985;139:60–5. PubMed
Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after Fontan operation at mid- and long-term follow-up. J Thorac Cardiovasc Surg 1993;106:1126–32. PubMed
Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, et al. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990;336:1087–90. PubMed
van Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 1999;82:40–6. PubMed PMC
Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 2001;11:62–6. PubMed
Rauch R, Ries M, Hofbeck M, et al. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 2000;83:678–82. PubMed
Jahangiri M, Shore D, Kakkar V, et al. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997;113:989–92. PubMed
Jahangiri M, Kreutzer J, Zurakowski D, et al. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 2000;120:778–82. PubMed
Ravn HB, Hjortdal VE, Stenbog EV, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001;85:61–5. PubMed PMC
Odegard KC, McGowan FX Jr, Zurakowski D, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 2003;125:1260–7. PubMed
Andrew M, Vegh P, Johnston M. Maturation of the hemostatic system during childhood. Blood 1992;80:1998–2005. PubMed
Monagle P, Andrew M. Coagulation abnormalities after Fontan procedures. J Thorac Cardiovasc Surg 1998;115:732–3. PubMed
Barnes C, Monagle P. Haemostatic changes following the modified Fontan procedure. Thromb Haemost 2001;86:1341–2. PubMed
Martinez J, Barsigian C. Coagulopathy of liver failure and vitamin K deficiency. In: Loscalzo J, Schafer AI, eds. Thrombosis and hemorrhage. Baltimore: Williams & Wilkins, 1998:987–1004.
Amitrano L, Guardascione MA, Brancaccio V, et al. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83–96. PubMed
Narkewicz MR, Sondheimer HM, Ziegler JW, et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 2003;36:352–7. PubMed
Monagle P, Cochrane A, McCrindle B, et al. Thromboembolic complications after Fontan procedures: the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 1998;115:493–8. PubMed
Balling G, Vogt M, Kaemmerer H, et al. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 2000;119:745–52. PubMed
Rosenthal DN, Bulbul ZR, Friedman AH, et al. Thrombosis of the pulmonary artery stump after distal ligation. J Thorac Cardiovasc Surg 1995;110:1563–5. PubMed
Odegard KC, McGowan FX Jr, Zurakowski D, et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 2002;73:1770–7. PubMed
Odegard KC, McGowan FX Jr, DiNardo JA, et al. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 2002;123:459–65. PubMed
Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo: a closer look. Thromb Haemost 2001;86:855–61. PubMed
Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol 2002;90:672–4. PubMed